Inventor
BARTLETT MARK J
US18 patents
⚠️ This page may combine multiple inventors who share the name “BARTLETT MARK J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GILEAD SCIENCES INC
17 patentsUS12180217B2Dec 31, 2024
Compounds and methods for treatment of viral infections
GILEAD SCIENCES INC3 citations84
US11851438B2Dec 26, 2023
1′-cyano nucleoside analogs and methods for treatment of viral infections
GILEAD SCIENCES INC9 citations84
US11845755B2Dec 19, 2023
Compounds and methods for treatment of viral infections
GILEAD SCIENCES INC7 citations84
US11780844B2Oct 10, 2023
Compounds and methods for treatment of viral infections
GILEAD SCIENCES INC7 citations84
US11203591B2Dec 21, 2021
Substituted 6-azabenzimidazole compounds
GILEAD SCIENCES INC6 citations82
US11925631B2Mar 12, 2024
Substituted 6-azabenzimidazole compounds
GILEAD SCIENCES INC2 citations72
US11071730B2Jul 27, 2021
Substituted 6-azabenzimidazole compounds
GILEAD SCIENCES INC4 citations72
US11897878B2Feb 13, 2024
Substituted 6-azabenzimidazole compounds
GILEAD SCIENCES INC2 citations71
US9951065B2Apr 24, 2018
Benzimidazole and imadazopyridine carboximidamide compounds
GILEAD SCIENCES INC3 citations68
US12448383B2Oct 21, 2025
Compounds and methods for treatment of viral infections
GILEAD SCIENCES INC0 citations61
US12258346B2Mar 25, 2025
Substituted 6-azabenzimidazole compounds
GILEAD SCIENCES INC0 citations61
US11229638B2Jan 25, 2022
Therapeutic heterocyclic compounds
GILEAD SCIENCES INC0 citations61
US11040033B2Jun 22, 2021
Therapeutic heterocyclic compounds
GILEAD SCIENCES INC1 citations61
US12110294B2Oct 8, 2024
CD73 compounds
GILEAD SCIENCES INC0 citations60
US11186579B2Nov 30, 2021
Therapeutic heterocyclic compounds
GILEAD SCIENCES INC0 citations50
US11098027B2Aug 24, 2021
Therapeutic heterocyclic compounds
GILEAD SCIENCES INC0 citations50
US11919869B2Mar 5, 2024
CD73 compounds
GILEAD SCIENCES INC0 citations47